Tag archive for ‘Teva Pharmaceuticals’
Niva Goldberg On Thursday, July 16th, 2015

Mylan battles against Teva takeover: US consumer groups oppose merger

“A takeover of Mylan by Teva is a bad deal for consumers, ” claim. US consumer organizations that have jointly written to the Federal Trade Commission (FTC) demanding that it block the Teva-Mylan More...

Vered Weiss On Monday, March 2nd, 2015

Teva Pharmaceuticals Sells Plants in Sellersville, PA

Israeli Teva Pharmaceuticals is raising funds by selling its plant  in Sellersville, Pennsylvania to G&W Labs. The move will help the company streamline operations and reduce costs.  Teva will sell rights More...

Gil Tanenbaum On Wednesday, October 22nd, 2014

Teva Signs Deal for Affordable Medicines in South Africa

Medpro Pharrmaceutica, a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa, has entered into a collaboration with Teva Pharmaceuticals, an affiliate of Israel’s More...

Vered Weiss On Thursday, October 16th, 2014

Initial U.S. Supreme Court Hearing Mixed on Teva’s Pharmaceuticals Patent Protection

– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for Copaxone, a multiple sclerosis drug that accounts More...

Gil Tanenbaum On Monday, May 26th, 2014

In Spite Of Recent Gains Goldman Gives Teva A Sell Order After Copaxone Patent Expired Sunday

– Teva investors are concerned about competition to the company’s Copaxone medication now that its patent has expired. Due to its failed attempt recently to block the marketing of a generic version of More...

Gil Tanenbaum On Sunday, May 25th, 2014

Israel’s Teva Pharmaceuticals Sued By California Counties Over Pain Killers

– Two California counties have filed a law suit against a number of pharmaceutical companies for allegedly promoting pain killer addiction. – California’s Orange and Santa Clara Couties have More...

Gali Raz On Wednesday, July 31st, 2013

UK Court of Appeal rules in favor of Teva regarding Copaxone patents

– Teva Pharmaceutical Industries Ltd. has chalked up a victory in the UK against Mylan Inc., stating that their Copaxone patents are valid through May 2015, after losing a similar court case in the More...

Alan Gallindoss On Wednesday, June 19th, 2013

Protalix Signs Agreement With Brazil Health Authorities : Worth up to $280 million

– – / By Alan Gallindoss / Protalix BioTherapeutics announced today, June 19th, 2013, that it has entered into a supply and technology transfer agreement with Fundação Oswaldo Cruz (Fiocruz), More...

Alan Gallindoss On Wednesday, June 12th, 2013

Malicious Tampering Likely Behind Furosemide Packaging Mix-up at Teva’s French Subsidiary

– May Have Led to a Number of Patient Deaths in France. –   / By Alan Gallindoss / Pharmaceutical trade magazine “in-pharmetechnologist.com” has been reporting on the apparently deliberate More...

Wordpress site Developed by Fixing WordPress Problems